| GOLDMAN SACHS EUROZONE EQUITY INCOME P CAP USD | RV EURO VALOR | 20,31% | 38,85% | 65,98% | 135,53% |
| JPM US SELECT EQUITY PLUS I (ACC) EUR (HEDGED) | RVI USA VALOR | 31,07% | 71,01% | 65,95% | 235,19% |
| BNP PARIBAS JAPAN EQUITY PRIVILEGE CAP | RVI JAPÓN | 39,23% | 65,15% | 65,93% | 129,25% |
| ALMA PLATINUM IV WINTON ALMA DIVERSIFIED MACRO I1C-U | GESTIÓN ALTERNATIVA | 18,53% | 22,25% | 65,92% | 50,23% |
| AMUNDI MSCI NORTH AMERICA ESG BROAD TRANSITION AU DIS | RVI USA | 30,32% | 56,84% | 65,92% | 213,84% |
| JPM US SELECT EQUITY C (DIST) USD | RVI USA | 28,24% | 54,74% | 65,91% | 239,46% |
| NINETY ONE GSF GLOBAL VALUE EQUITY FUND A ACC USD | RVI GLOBAL VALOR | 29,98% | 52,21% | 65,89% | · |
| PRIVILEDGE - FIDELITY TECHNOLOGY (EUR) M CAP SYST. HDG | TMT | 43,21% | 82,62% | 65,88% | · |
| GOLDMAN SACHS EUROZONE EQUITY INCOME P CAP EUR | RV EURO VALOR | 20,48% | 38,96% | 65,86% | 135,34% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C CAP USD | BIOTECNOLOGÍA | 59,13% | 50,20% | 65,85% | 161,01% |
